MMP2 and prostate carcinoma: αvβ6 has been shown to be expressed in prostate cancer bone metastases, and in vivo models of bone metastasis have shown that αvβ6 promotes osteolysis through upregulation of MMP-2 and parathyroid hormone-related protein [118].